KIF16B expression was also implicated in the growth of pre-metastatic tumours in human models of the lung-to-brain metastasis, and low mRNA expression of KIF16B was associated with poor disease-free survival in LUAD patients [227], indicating its prognostic significance in lung cancer. This evidence concerns the gene KIF16B and neoplasm.